266 related articles for article (PubMed ID: 30876792)
1. NK cell expression of Tim-3: First impressions matter.
So EC; Khaladj-Ghom A; Ji Y; Amin J; Song Y; Burch E; Zhou H; Sun H; Chen S; Bentzen S; Hertzano R; Zhang X; Strome SE
Immunobiology; 2019 May; 224(3):362-370. PubMed ID: 30876792
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory receptor Tim-3 fails to suppress IFN-γ production via the NFAT pathway in NK-cell, unlike that in CD4
Yu X; Lang B; Chen X; Tian Y; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Jiang Y
BMC Immunol; 2021 Apr; 22(1):25. PubMed ID: 33832435
[TBL] [Abstract][Full Text] [Related]
3. Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodies.
Lin W; Voskens CJ; Zhang X; Schindler DG; Wood A; Burch E; Wei Y; Chen L; Tian G; Tamada K; Wang LX; Schulze DH; Mann D; Strome SE
Blood; 2008 Aug; 112(3):699-707. PubMed ID: 18519814
[TBL] [Abstract][Full Text] [Related]
4. Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer.
Guo Z; Cheng D; Xia Z; Luan M; Wu L; Wang G; Zhang S
J Transl Med; 2013 Sep; 11():215. PubMed ID: 24044888
[TBL] [Abstract][Full Text] [Related]
5. Tim-3 and PD-1 blocking cannot restore the functional properties of natural killer cells in early clinical stages of chronic lymphocytic leukemia: An
Astaneh M; Rezazadeh H; Hossein-Nataj H; Shekarriz R; Zaboli E; Shabani M; Asgarian-Omran H
J Cancer Res Ther; 2022; 18(3):704-711. PubMed ID: 35900543
[TBL] [Abstract][Full Text] [Related]
6. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
[TBL] [Abstract][Full Text] [Related]
7. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer.
Zheng Y; Li Y; Lian J; Yang H; Li F; Zhao S; Qi Y; Zhang Y; Huang L
J Transl Med; 2019 May; 17(1):165. PubMed ID: 31109341
[TBL] [Abstract][Full Text] [Related]
8. Tim-3 and its role in regulating anti-tumor immunity.
Das M; Zhu C; Kuchroo VK
Immunol Rev; 2017 Mar; 276(1):97-111. PubMed ID: 28258697
[TBL] [Abstract][Full Text] [Related]
9. Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss.
Li Y; Zhang J; Zhang D; Hong X; Tao Y; Wang S; Xu Y; Piao H; Yin W; Yu M; Zhang Y; Fu Q; Li D; Chang X; Du M
Sci Signal; 2017 Sep; 10(498):. PubMed ID: 28951537
[TBL] [Abstract][Full Text] [Related]
10. Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells.
Snyder KM; Hullsiek R; Mishra HK; Mendez DC; Li Y; Rogich A; Kaufman DS; Wu J; Walcheck B
Front Immunol; 2018; 9():2873. PubMed ID: 30574146
[TBL] [Abstract][Full Text] [Related]
11. Modulation of CXCR1 and CXCR3 expression on NK cells via Tim-3 in a murine model of primary biliary cholangitis.
Xu J; Fu H; Yang Y; Yu H; Ai X; Lei Y; Bao W; Tang Y
Mol Immunol; 2021 Jul; 135():342-350. PubMed ID: 33984607
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 enhances NK cell activation in response to antibody-coated targets.
Roda JM; Parihar R; Lehman A; Mani A; Tridandapani S; Carson WE
J Immunol; 2006 Jul; 177(1):120-9. PubMed ID: 16785506
[TBL] [Abstract][Full Text] [Related]
13. The functional potency of natural killer cells in response to IL-2/IL-15/IL-21 stimulation is limited by a concurrent upregulation of Tim-3 in bladder cancer.
Zhang W; Feng H; Chen Q; Lu X; Ge J
Exp Cell Res; 2018 Nov; 372(2):92-98. PubMed ID: 30243902
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.
Cheng YQ; Ren JP; Zhao J; Wang JM; Zhou Y; Li GY; Moorman JP; Yao ZQ
Immunology; 2015 Aug; 145(4):485-97. PubMed ID: 25772938
[TBL] [Abstract][Full Text] [Related]
15. Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.
Xu L; Huang Y; Tan L; Yu W; Chen D; Lu C; He J; Wu G; Liu X; Zhang Y
Int Immunopharmacol; 2015 Dec; 29(2):635-641. PubMed ID: 26428847
[TBL] [Abstract][Full Text] [Related]
16. Decreased TIM-3 expression of peripheral blood natural killer cells in patients with severe aplastic anemia.
Zhang T; Yuan X; Liu C; Li Y; Liu H; Li L; Ding K; Wang T; Wang H; Shao Z; Fu R
Cell Immunol; 2017 Aug; 318():17-22. PubMed ID: 28637584
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia.
Hadadi L; Hafezi M; Amirzargar AA; Sharifian RA; Abediankenari S; Asgarian-Omran H
Oncol Res Treat; 2019; 42(4):202-208. PubMed ID: 30870839
[TBL] [Abstract][Full Text] [Related]
18. Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway.
Sun J; Yang M; Ban Y; Gao W; Song B; Wang Y; Zhang Y; Shao Q; Kong B; Qu X
PLoS One; 2016; 11(1):e0147186. PubMed ID: 26789128
[TBL] [Abstract][Full Text] [Related]
19. Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling.
Tan S; Xu Y; Wang Z; Wang T; Du X; Song X; Guo X; Peng J; Zhang J; Liang Y; Lu J; Peng J; Gao C; Wu Z; Li C; Li N; Gao L; Liang X; Ma C
Cancer Res; 2020 Mar; 80(5):1130-1142. PubMed ID: 31848194
[TBL] [Abstract][Full Text] [Related]
20. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
